CL264

CAS No. 1510712-69-2

CL264( —— )

Catalog No. M26120 CAS No. 1510712-69-2

CL264, a specific agonist of TLR7, is used for innate immune signals research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 124 In Stock
5MG 112 In Stock
10MG 192 In Stock
25MG 304 In Stock
50MG 412 In Stock
100MG 548 In Stock
200MG 739 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CL264
  • Note
    Research use only, not for human use.
  • Brief Description
    CL264, a specific agonist of TLR7, is used for innate immune signals research.
  • Description
    CL264, a specific agonist of TLR7, is used for innate immune signals research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1510712-69-2
  • Formula Weight
    413.438
  • Molecular Formula
    C19H23N7O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (60.47 mM)
  • SMILES
    CCCCNc1nc(N)c2[nH]c(=O)n(Cc3ccc(cc3)C(=O)NCC(O)=O)c2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.William CraigStagner, et al. Chapter Five - Sucrose octaacetate. Profiles of Drug Substances, Excipients and Related Methodology. Volume 44, 2019, Pages 267-291.
molnova catalog
related products
  • TLR7 agonist 3

    TLR7 agonist 3 is a Toll-like receptor 7 (TLR7) agonist that has anticancer activity and is used in the study of diseases of the immune system.

  • Semapimod

    Semapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production, inhibits TLR4 signaling (IC50=0.3 uM) .

  • ODN 1826

    ODN 1826 is a 20-mer DNA strand, a TLR9 agonist and an immunostimulant, with anti-tumor and cardioprotective effects, promoting apoptosis, and stimulating the production of NO and iNOS. ODN 1826 is a CpG DNA mimetic that can be used as an adjuvant for synthetic vaccines.